Evaluation

 

Evaluation 2025

In 2025, the independent, non-profit and autonomous research institute WPZ Research GmbH conducted a comprehensive review of the institute – both in terms of the methodological and content-related quality of its work and the efficiency of its work and use of resources.
 

Evaluation result
Summary

Regular external evaluations constitute an essential element of our quality assurance framework. The AIHTA (as LBI-HTA) has successfully undergone three evaluations. A further evaluation is currently in progress and is expected to be concluded shortly.

Evaluation 2016

  • Dr. Christian Affolter (Head of Public Affairs and Health policy, CSS Insurance, Lucerne, Switzerland)
  • Falk Ehmann, MD, PhD, MSc (Expert in drugs)
  • Prof. Dr. Kirsten Steinhausen (absent due to illness)
  • Bettina Zirpel (German Research Foundation, DFG, Bonn), Germany (reporter)

Evaluation result

On-site visit 2011

  • Albert (Bert) Boer, MD, PhD, Director, Zorginstituut Nederland (ZIN) formerly Health Care Insurance Board (CVZ) , The Netherlands
  • Raf Mertens, MD, Director, Belgian Health Care Knowledge Center (KCE), Belgium
  • Prof. Peter Kolominsky-Rabas, MD, Director, Interdisciplinary Center for Public Health (IZPH), University of Erlangen-Nürnberg, Germany

Evaluation result

Interim evaluation 2009

  • Prof. John Gabbay, Emeritus professor of Public Health, University of Southampton, UK
  • Prof. Andrew Stevens, Professor of Public Health, University of Birmingham, UK
  • Prof. Stefan Willich, MD, MPH, Director, Institute for Social Medicine, Epidemiology and Health Economics, Charité Berlin, Germany
  • Simon Sommer, Evaluation expert, Jacobs Foundation Zurich, Switzerland

Evaluation result